Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05125471 · ClinicalTrials.gov registry record · Phase 2
Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study)
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT05125471 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 3 participants.
The verdict
NCT05125471, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this open-label study is to evaluate the safety and efficacy of cobimetinib in extracranial AVM.
Interventions
- DRUG Cobimetinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-07-26 |
| Est. Completion | 2025-09-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05125471
The ClinicalTrials.gov registry entry for NCT05125471 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cobimetinib is the first listed.
NCT05125471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05125471 about?
NCT05125471 is a clinical study titled "Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study)". The purpose of this open-label study is to evaluate the safety and efficacy of cobimetinib in extracranial AVM.
What is the current status of trial NCT05125471?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2022-07-26. Estimated completion is 2025-09-03.
What interventions are being tested in trial NCT05125471?
The interventions under investigation include: Cobimetinib (DRUG).
Who is sponsoring clinical trial NCT05125471?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.